{"disease":{"id":"perioperative-immunotherapy","name":"perioperative immunotherapy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07109401","title":"Perioperative Immunotherapy for Resectable Limited-Stage SCLC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":37,"lead_sponsor_name":"Fudan University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}